insitro (@insitro) — Twitter Score 8 out of 1000
Fair
8Ranked #114,380 of 493,952 crypto accounts tracked by TwitterScore.io
Tarun Chitra
Antonio García Martínez (agm.eth)
roon
Martin Shkreli
knower
Riva
Upgrade to see this data
Upgrade to see this data
Upgrade to see this data
Smart Followers
Unlock instant search across all smart followers, plus categories, trending alpha and bulk score checks.
Unlock instant search across all smart followers, plus categories, trending alpha and bulk score checks.
| Username | Following Date | Twitter Score | Followers | Smart Followers | Description |
|---|---|---|---|---|---|
|
|
|||||
About insitro's Twitter Score
Insitro is an AI therapeutics and drug-discovery company that combines machine learning with large-scale human genetics and experimental biology to develop novel medicines. Insitro's Twitter Score is 7.9 out of 1000 as of October 2026, ranking #114,380 among 493,952 tracked accounts.
Insitro was founded by Daphne Koller and has built its platform around two core technologies: Virtual Human, a genetically anchored causal-AI engine, and TherML, a modality-agnostic therapeutic-design engine. The company announced the acquisition of CombinAbleAI and the formal launch of TherML in January 2026, and had previously acquired Haystack Sciences, a high-throughput chemistry platform for machine-learning-driven molecular design.
Insitro announced a $400 million Series C financing in March 2021, led by CPP Investments, per the company's announcement. Its lead MASH therapeutic candidate, CTRO-1013, remained in IND-enabling studies as of June 2026 and was expected to enter first-in-human clinical trials during 2026. Insitro previously held a collaboration with Gilead Sciences.
Insitro maintains active partnerships with several major pharmaceutical companies. A collaboration with Bristol Myers Squibb that began in 2020 continued to advance, with BMS nominating two additional targets and Insitro reporting a $10 million milestone payment in March 2026. In October 2024, Insitro entered three strategic agreements with Eli Lilly and Company focused on potential metabolic-disease medicines. In March 2025, Insitro and the INSIGHT Health Data Research Hub at Moorfields Eye Hospital announced a collaboration to develop an AI foundation model for neurodegeneration research.
Insitro has published 403 posts on the platform and has been mentioned by 40 accounts, with 102 total mentions, reflecting sustained attention from the broader crypto and biotech-adjacent community. The account has 6,624 followers as of October 2026.
Who follows Insitro on X?
The accounts that follow Insitro include 32 founders, 7 angel investors, 3 influencers and 4 VCs. Among its notable followers are Tarun Chitra, Antonio Garca Martnez agm.eth, Roon, Martin Shkreli, Knower and Riva.
